SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Aguirre Blaise A.

(Last) (First) (Middle)
C/O GILLA INC.
15540 BISCAYNE BLVD

(Street)
NORTH MIAMI FL US 33160

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GILLA INC. [ GLLA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/09/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/09/2015 04/13/2015 P 157,143(1) A $0.07 1,080,583(4) D
Common Stock 04/09/2015 04/13/2015 P 71,429(2) A $0.07 1,152,012(4) D
Common Stock 04/09/2015 04/13/2015 P 2,385(3) A $0.15 1,154,397(4) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Dr. Aguirre converted certain of the Issuer's Unsecured Subordinated Convertible Debentures (the "Debentures"), with a face amount of $11,000, into 157,143 shares of Common Stock at a conversion price of $0.07 per share. The 157,143 shares of Common Stock were issued to Dr. Aguirre on April 13, 2015.
2. Dr. Aguirre converted certain of the Debentures, with a face amount of $5,000, into 71,429 shares of Common Stock at a conversion price of $0.07 per share. The 71,429 shares of Common Stock were issued to Dr. Aguirre on April 13, 2015.
3. Dr. Aguirre accepted, in satisfaction of amounts due to him as interest on the Debentures, 2,385 shares of Common Stock, based on a conversion price for such amounts due as interest of $0.15 per share. The 2,385 shares of Common Stock were issued to Dr. Aguirre on April 13, 2015.
4. Includes 59,000 shares of Common Stock owned by Dr. Aguirre's wife.
/s/ Blaise Aguirre 04/21/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.